Aprogen Medicines Statistics

Total Valuation

KRX:007460 has a market cap or net worth of KRW 219.07 billion. The enterprise value is 672.64 billion.

Market Cap	219.07B
Enterprise Value	672.64B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:007460 has 308.55 million shares outstanding. The number of shares has increased by 16.63% in one year.

Current Share Class	308.55M
Shares Outstanding	308.55M
Shares Change (YoY)	+16.63%
Shares Change (QoQ)	+3.55%
Owned by Insiders (%)	6.93%
Owned by Institutions (%)	2.10%
Float	188.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.74
PB Ratio	0.45
P/TBV Ratio	2.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.21
EV / Sales	5.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.72

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.51.

Current Ratio	0.99
Quick Ratio	0.62
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	-7.27
Interest Coverage	-3.75

Financial Efficiency

Return on equity (ROE) is -31.66% and return on invested capital (ROIC) is -9.79%.

Return on Equity (ROE)	-31.66%
Return on Assets (ROA)	-8.84%
Return on Invested Capital (ROIC)	-9.79%
Return on Capital Employed (ROCE)	-18.03%
Revenue Per Employee	492.55M
Profits Per Employee	-198.96M
Employee Count	256
Asset Turnover	0.18
Inventory Turnover	1.35

Taxes

Income Tax	-884.92M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.31% in the last 52 weeks. The beta is 0.03, so KRX:007460's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-20.31%
50-Day Moving Average	658.26
200-Day Moving Average	689.61
Relative Strength Index (RSI)	54.69
Average Volume (20 Days)	6,537,533

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:007460 had revenue of KRW 126.09 billion and -50.93 billion in losses. Loss per share was -175.67.

Revenue	126.09B
Gross Profit	33.71B
Operating Income	-101.30B
Pretax Income	-148.37B
Net Income	-50.93B
EBITDA	-77.21B
EBIT	-101.30B
Loss Per Share	-175.67

Full Income Statement

Balance Sheet

The company has 124.70 billion in cash and 248.05 billion in debt, giving a net cash position of -123.35 billion or -399.78 per share.

Cash & Cash Equivalents	124.70B
Total Debt	248.05B
Net Cash	-123.35B
Net Cash Per Share	-399.78
Equity (Book Value)	488.30B
Book Value Per Share	516.68
Working Capital	-1.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.27 billion and capital expenditures -14.84 billion, giving a free cash flow of -34.11 billion.

Operating Cash Flow	-19.27B
Capital Expenditures	-14.84B
Free Cash Flow	-34.11B
FCF Per Share	-110.56

Full Cash Flow Statement

Margins

Gross margin is 26.73%, with operating and profit margins of -80.33% and -40.39%.

Gross Margin	26.73%
Operating Margin	-80.33%
Pretax Margin	-117.67%
Profit Margin	-40.39%
EBITDA Margin	-61.23%
EBIT Margin	-80.33%
FCF Margin	n/a

Dividends & Yields

KRX:007460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.63%
Shareholder Yield	-16.63%
Earnings Yield	-23.25%
FCF Yield	-15.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Dec 28, 2022
Split Type	Reverse
Split Ratio	0.3333333333

Scores

KRX:007460 has an Altman Z-Score of -0.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.65
Piotroski F-Score	1